Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by a1broker1

T.SVC

Accumulation continues

Another day of extremely heavy volume with another increase in share price as...

February 1, 2012

T.SVC

Takeover Candidate

Sandvine is quite likely to be the next Canadian technology company to be...

January 31, 2012

T.SVC

Institutional Accumulation

The heavy volume accompanied by a rising stock price is clearly indicative of...

January 31, 2012

T.SVC

Normal Course Issuer Bid, NCIB

With a Normal Course Issuer Bid or NCIB, a company can buy shares in the...

January 31, 2012

T.SVC

Normal Course Issuer Bid, NCIB

With a Normal Course Issuer Bid or NCIB, a company can buy shares in the...

January 31, 2012

T.QTRH

New Analyst Target

Northern Securities technology analyst has upgraded his target for MSD to $45...

August 20, 2011

Prev 1 2 3

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »